Jacques Olivier Bay

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi et al. · Nature Medicine · 2022 · 383 citations · Full text

Medicine, Hematology, Oncology +15

Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database

Sébastien Salas, Noémie Resseguier, Jean‐Yves Blay et al. · Annals of Oncology · 2017 · 172 citations · Full text

Medicine, Clinical Sciences, Oncology +17

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results.

Michel Legros, J Dauplat, J Fleury et al. · Journal of Clinical Oncology · 1997 · 97 citations

Medicine, Oncology, Surgery +17

Do cytokines improve survival in patients with metastatic renal cell carcinoma (MRCC) of intermediate prognosis? Results of the prospective randomized PERCY Quattro trial

Sylvie Négrier, David Pérol, Alain Ravaud et al. · Journal of Clinical Oncology · 2005 · 89 citations

Medicine, Immunology, Oncology +17

Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study

Caroline Houillier, Hervé Ghesquières, Cécile Moluçon‐Chabrot et al. · Journal of Neuro-Oncology · 2017 · 56 citations

Medicine, Oncology, Pharmacotherapy +11